Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
XGN
#4161
Exagen Inc. Common Stock
3.0
4
USD
+2.36%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.36%
Changement Mensuel
-0.98%
Evolution sur 6 mois
-73.91%
Changement Annuel
-34.62%
Clôture Précédente
2.9
7
Open
3.0
4
Bid
Ask
Low
3.0
4
High
3.0
4
Volume
35
Marchés
Actions des Marchés US
Soins de Santé
XGN
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
12.67 M
16.23 M
16.83 M
17.24 M
17.9 M
24.05 M
—
Valuation ratios
Enterprise value
136.45 M
116.8 M
13.31 M
20.43 M
73.93 M
137.95 M
594.52 M
Price to earnings ratio
—
-6.92
-0.89
-1.47
-4.94
-6.54
-30.6
Price to sales ratio
—
3.85
0.92
0.66
1.34
1.97
8.87
Price to cash flow ratio
—
-9.16
-1.31
-2.41
-5.62
-9.62
-42.17
Price to book ratio
—
2.19
0.99
1.53
7.82
7.51
15.77
Enterprise value to EBITDA ratio
-7.48
-3.86
0.46
0.12
-4.24
-9.19
-43.74
Profitability ratios
Return on assets %
-0.21
-0.22
-0.55
-0.42
-0.34
-0.34
-0.36
Return on equity %
-0.4
-0.32
-1.12
-1.04
-1.58
-1.14
-1.46
Return on invested capital %
-537.22
-722.54
-1 215.58
-709.69
-519.66
-434.32
-323.94
Gross margin %
60.55
57.37
46.86
56.06
59.51
58.28
233.08
Operating margin %
-36.18
-49.83
-101.07
-43.46
-24.51
-21.13
-84.89
EBITDA margin %
-34.99
-47.97
-99.93
-39.97
-21.76
-18.63
-72.28
Net margin %
-39.75
-55.59
-104
-45.08
-27.17
-29.97
-119.21
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.04
12.1
7.55
4.02
2.7
3.45
14.81
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.5
0.48
0.43
0.73
1.09
1.3
1.27
Solvency ratios
Debt to assets ratio
0.34
0.22
0.4
0.4
0.51
0.41
1.67
Debt to equity ratio
0.64
0.32
0.81
1.01
2.37
1.37
6.84
Long term debt to total assets ratio
0.34
0.22
0.33
0.34
0.44
0.38
1.57
Long term debt to total equity ratio
0.64
0.32
0.68
0.85
2.08
1.28
6.44
Per share metrics
Operating cash flow per share
—
-1.27
-1.88
-0.82
-0.73
-0.63
-0.72
EBIT per share
—
-1.51
-2.7
-1.29
0.49
0.64
0.65
EBITDA per share
—
-1.45
-2.67
-1.19
-0.66
-0.58
-0.57
Total debt per share
—
1.72
2.01
1.3
1.24
1.11
4.29
Cash per share
—
6.23
3.65
2.06
1.21
1.49
5.08
Net current asset value per share
—
7.06
4.25
2.71
2
2.27
8.73
Tangible book value per share
—
4.97
2.49
1.28
0.52
0.81
2.94
Working capital per share
—
6.47
3.69
2.03
1.26
1.61
6.27
Book value per share
—
5.32
2.49
1.28
0.52
0.81
2.94
Nouvelles
KeyBanc cuts Exagen stock price target on pricing headwinds
Exagen Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-03-11
L’objectif de cours d’Exagen abaissé à 10$ par Canaccord sur les perspectives de marge
Exagen stock price target lowered to $10 by Canaccord on margin outlook
BTIG abaisse l’objectif de cours d’Exagen à 9$ sur fond de prévisions de revenus réduites
BTIG cuts Exagen stock price target to $9 on lower revenue outlook
Exagen conserve sa note de surperformance chez William Blair
Exagen stock maintains Outperform rating at William Blair
Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates
Le BPA de Exagen a manqué les attentes de 0,01$, le CA en dessous des prévisions
Exagen earnings missed by $0.01, revenue fell short of estimates
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates